Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis

British Journal of Dermatology

Volumn 162, Issue 5, 2010, Pages 1038-1043

  Yu, B ^a,b   Shao, Y ^a,b   Zhang, J ^a,b   Dong, X L ^a   Liu, W L ^a   Yang, H ^a,c   Liu, L ^a   Li, M H ^a   Yue, C F ^a   Fang, Z Y ^a   Zhang, C ^a   Hu, X P ^b   Chen, B C ^b   Wu, Q ^a   Chen, Y W ^d   Zhang, W ^d   Wan, J ^a,e  

^a Biomedical Research Institute   (China)

^b Departments of Dermatology   (France)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^d JINAN UNIVERSITY   (China)

^e HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Atopic dermatitis; Histamine receptor H4; HRH4; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; HISTAMINE H4 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77951232193     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09675.x     Document Type: Article

References (29)

1. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996 34 : 760 764.
2. Williams HC. Dermatology. In : Health Care Needs Assessment (Stevens A, Raferty J, eds 2nd edn.
3. Kuster W, Petersen M, Christophers E et al. A family study of atopic dermatitis. Clinical and genetic characteristics of 188 patients and 2,151 family members. Arch Dermatol Res 1990 282 : 98 102.
4. Lee YA, Wahn U, Kehrt R et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000 26 : 470 473.
5. Cookson WO, Ubhi B, Lawrence R et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001 27 : 372 373.
6. Bradley M, Soderhall C, Luthman H et al. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 2002 11 : 1539 1548.
7. Esparza-Gordillo J, Weidinger S, Folster-Holst R et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009 41 : 596 601.
8. Macaluso F, Nothnagel M, Parwez Q et al. Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis. Exp Dermatol 2007 16 : 692 698.
9. Purwar R, Langer K, Werfel T. Polymorphisms within the C3 gene are associated with specific IgE levels to common allergens and super-antigens among atopic dermatitis patients. Exp Dermatol 2009 18 : 30 4.
10. Sengler C, Haider A, Sommerfeld C et al. Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy 2003 33 : 166 169.
11. O'Regan GM, Irvine AD. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 2008 8 : 406 410.
12. O'Regan GM, Sandilands A, McLean WH et al. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008 122 : 689 693.
13. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006 38 : 441 446.
14. Jutel M, Watanabe T, Akdis M et al. Immune regulation by histamine. Curr Opin Immunol 2002 14 : 735 740.
15. Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006 533 : 69 76.
16. Dijkstra D, Stark H, Chazot PL et al. Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol 2008 128 : 1696 1703.
17. Zhang M, Venable JD, Thurmond RL. The histamine H4 receptor in autoimmune disease. Expert Opin Investig Drugs 2006 15 : 1443 1452.
18. Coge F, Guenin SP, Rique H et al. Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun 2001 284 : 301 309.
19. Oda T, Morikawa N, Saito Y et al. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000 275 : 36781 36786.
20. Haagerup A, Bjerke T, Schiotz PO et al. Atopic dermatitis - a total genome-scan for susceptibility genes. Acta Derm Venereol (Stockh) 2004 84 : 346 352.
21. Haagerup A, Borglum AD, Binderup HG et al. Fine-scale mapping of type I allergy candidate loci suggests central susceptibility genes on chromosomes 3q, 4q and Xp. Allergy 2004 59 : 88 94.
22. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980 92 (Suppl 44 7.
23. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008 3 : 1101 1108.
24. T) method. Methods 2001 25 : 402 408.
25. Hofstra CL, Desai PJ, Thurmond RL et al. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003 305 : 1212 1221.
26. Gutzmer R, Diestel C, Mommert S et al. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 2005 174 : 5224 5232.
27. Ling P, Ngo K, Nguyen S et al. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004 142 : 161 171.
28. Baumer W, Wendorff S, Gutzmer R et al. Histamine H4 receptors modulate dendritic cell migration through skin - immunomodulatory role of histamine. Allergy 2008 63 : 1387 1394.
29. Horr B, Borck H, Thurmond R et al. STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. Int Immunopharmacol 2006 6 : 1577 1585.